Ultime notizie per Celanese (NYSE:CE) Azioni

Celanese

Celanese is one of the world's largest producers of acetic acid and its downstream derivative chemicals, which are used in various end markets, including coatings and adhesives. The company is also one of the largest producers of specialty polymers, which are used in the automotive, electronics, medical, building, and consumer end markets. The company also makes cellulose derivatives used in cigarette filters.

Celanese Corp

CEA Industries Inc

Creations Inc

CENTRAL AUTOMOTIVE PRODS by Central Automotive Products Ltd.

Central Automotive Products Ltd

China Eastern Airlines Corp Ltd ADR

CHINA EVERBRIGHT BANK ORD by China Everbright Bank Co Ltd.

China Everbright Bank Co Ltd

CITYCHAMP WATCH & JEWELLE by Citychamp Watch & Jewellery Group Ltd.

Citychamp Watch & Jewellery Group Ltd

Cebu Air Inc

CANASIA ENERGY CORP by CANASIA ENERGY CORP.

CanAsia Energy Corp

Saltbae Capital Corp

Cecil Bancorp Inc

CECO Environmental Corp

The Central and Eastern Europe Fund, Inc. (The) Common Stock

CENTRAL & EASTERN EUROPE FUND, INC.

Ceres Inc

CEEK VR

UpSnap Inc

Sprott Physical Gold and Silver Trust Units

Sprott Physical Gold and Silver Trust

Global X S&P Catholic Values Developed ex-U.S. ETF

CENTRAL FLA ST BK BELLEVW by Central Florida State Bank (Belleview FL)

COMML NATL FINCL CRP MICH by Commercial National Financial Corp (MI)

Commercial National Financial Corp (MI)

ETRACS Monthly Pay 1.5X Leveraged Closed-End Fund Index ETN

Saba Closed-End Funds ETF

Constellation Energy Corporation - Common Stock

Constellation Energy Corp

CHINA ED GROUP HLDGS LTD by CHINA ED GROUP HLDGS LTD.

China Education Group Holdings Ltd

CERRO GRANDE MINING CORP by Cerro Grande Mining Corp.

Cerro Grande Mining Corp

COSMO ENERGY HLDGS CO LTD by Cosmo Energy Hldgs Co Ltd

Cosmo Energy Holdings Co Ltd

Camber Energy Inc OM PAR $0.001 2022 NEW

COELACANTH ENERGY INC by COELACANTH ENERGY INC

Coelacanth Energy Inc

Camber Energy Inc

CONSOL Energy Inc

Cresco Ltd

Celsius - United States Dollar

Celcuity Inc

Bristol-Myers Squibb Company Celegne Contingent Value Rights

Celsius Holdings Inc

CELLCOM ISRAEL LTD ORD by Cellcom Israel, Ltd.

Cellcom Israel Ltd

Cellframe

Celo - United States Dollar

Celer Network - United States Dollar

Centamin PLC

Celularity Inc

PREFERRED COMMERCE INC by Preferred Commerce Inc.

Preferred Commerce Inc

Celexpress Inc

Creative Medical Technology Holdings, Inc. - Common Stock

Creative Medical Technology Holdings Inc

ClearBridge MLP & Midstream Fund Inc Com (New)

iShares J.P. Morgan EM Corporate Bond ETF

CEN Biotech Inc

Caravan Energy Corp Ordinary Shares

CareNet Inc

Cenntro Inc

CENNZnet

Central Garden & Pet Company - Common Stock

Central Garden & Pet Co

Central Garden & Pet Company - Class A Common Stock Nonvoting

Century Aluminum Co

CEO America Inc

CeCors Inc

Cantor Equity Partners, Inc. - Class A ordinary shares

Cantor Equity Partners Inc

CEPS PLC

Central Puerto S.A. American Depositary Shares (each represents ten Common Shares)

Central Puerto SA

Crestwood Equity Partners LP Unit Ltd Partnership Int (New)

CERES INC OM NEW

Cere Network

CERES GLOBAL AG CORP ORD by Ceres Global Ag Corp.

Ceres Global Ag Corp

CERo Therapeutics Holdings, Inc. - Common Stock

CERo Therapeutics Holdings Inc

CERo Therapeutics Holdings, Inc. - Warrants

Cerus Corp

Certara Inc

COLOMBIA ENERGY RESOUR by Colombia Energy Resources, Inc.

Colombia Energy Resources Inc

SPDR Series Trust SPDR Bloomberg Enhanced Roll Yield Commodity Strategy No K-1 ETF

CES ENERGY SOLUTIONS ORD by CES Energy Solutions Corp.

CES Energy Solutions Corp

Chesser Resources Ltd

CHINESE ESTS HLDGS ORD by Chinese Estates Holdings Ltd.

Chinese Estates Holdings Ltd

CHINESE ESTS HLD UNSP/ADR by Chinese Estates Holdings Ltd.

CES Synergies Inc

Central Securities Corporation Common Stock

Central Securities Corp

CoinEx Token

ACT Energy Technologies Ltd

ACT ENERGY TECHS LTD by ACT Energy Technologies Ltd.

DriveWealth ETF Trust DriveWealth NYSE 100 Index ETF

CAPITAL CITY ENERGY GROUP by Capital City Energy Group, Inc.

21Shares Core Ethereum ETF

CYBER ENVIRO-TECH INC. by Cyber Enviro-Tech Inc.

Cyber Enviro-Tech Inc

CHINA ECOTOURISM GRP NEW by CHINA ECOTOURISM GROUP LTD.

CETUS CAP ACQUISITION CORP L A

CETUS CAP ACQUISITION CORP RT

CETUS CAP ACQUISITION CORP UNIT 1 CL A & 1 WT EXP & 1 RT

CETUS CAP ACQUISITION CORP WT EXP

Cemtrex Inc

Clean Energy Technologies, Inc. - Common Stock

Clean Energy Technologies Inc

Across the recent three months, 14 analysts have shared their insights on Celanese (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>), expressing a variety of opinions spanning from bullish to bearish.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">7</td>
<td align="right">2</td>
<td align="right">1</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">5</td>
<td align="right">2</td>
<td align="right">1</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $112.86, a high estimate of $163.00, and a low estimate of $76.00. This current average represents a 24.1% decrease from the previous average price target of $148.69. 
<img src="https://www.benzinga.com/files/images/story/2024/1732042869_0.png" alt="price target chart" />
<h2>Analyzing Analyst Ratings: A Detailed Breakdown</h2>
The standing of Celanese among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Michael Leithead</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$88.00</td>
<td>$101.00</td>
</tr>
<tr>
<td>Joshua Spector</td>
<td>UBS</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$97.00</td>
<td>$161.00</td>
</tr>
<tr>
<td>John McNulty</td>
<td>BMO Capital</td>
<td>Lowers</td>
<td>Underperform</td>
<td>$76.00</td>
<td>$138.00</td>
</tr>
<tr>
<td>Charles Neivert</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$98.00</td>
<td>$150.00</td>
</tr>
<tr>
<td>Arun Viswanathan</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$122.00</td>
<td>$163.00</td>
</tr>
<tr>
<td>Michael Leithead</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$101.00</td>
<td>$151.00</td>
</tr>
<tr>
<td>Ghansham Panjabi</td>
<td>Baird</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$110.00</td>
<td>$150.00</td>
</tr>
<tr>
<td>Vincent Andrews</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$100.00</td>
<td>$140.00</td>
</tr>
<tr>
<td>David Begleiter</td>
<td>Deutsche Bank</td>
<td>Lowers</td>
<td>Buy</td>
<td>$110.00</td>
<td>$135.00</td>
</tr>
<tr>
<td>Kieran De Brun</td>
<td>Mizuho</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$120.00</td>
<td>$132.00</td>
</tr>
<tr>
<td>Michael Sison</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$115.00</td>
<td>$165.00</td>
</tr>
<tr>
<td>Kevin McCarthy</td>
<td>Vertical Research</td>
<td>Announces</td>
<td>Sell</td>
<td>$130.00</td>
<td>-</td>
</tr>
<tr>
<td>Arun Viswanathan</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$163.00</td>
<td>$167.00</td>
</tr>
<tr>
<td>Charles Neivert</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$150.00</td>
<td>$180.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Celanese. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Celanese compared to the broader market.</li>
<li>Price Targets: Delving into movements, analysts provide estimates for the future value of Celanese's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Celanese's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/CE/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Celanese analyst ratings.</a>
<h2>About Celanese</h2>
Celanese is one of the world's largest producers of acetic acid and its downstream derivative chemicals, which are used in various end markets, including coatings and adhesives. The company is also one of the largest producers of specialty polymers, which are used in the automotive, electronics, medical, building, and consumer end markets. The company also makes cellulose derivatives used in cigarette filters.
<h3>Celanese: Delving into Financials</h3>
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
Revenue Challenges: Celanese's revenue growth over 3 months faced difficulties. As of 30 September, 2024, the company experienced a decline of approximately -2.75%. This indicates a decrease in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Materials sector.
Net Margin: Celanese's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 4.38%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 1.61%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): Celanese's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of 0.45%, the company may face hurdles in achieving optimal financial returns.
Debt Management: With a high debt-to-equity ratio of 1.83, Celanese faces challenges in effectively managing its debt levels, indicating potential financial strain.
<h2>Analyst Ratings: What Are They?</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings

Cracking The Code: Understanding Analyst Reviews For Celanese

Barclays analyst Michael Leithead maintains Celanese (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>) with a Equal-Weight and lowers the price target from $101 to $88.

News

Price Target

Barclays Maintains Equal-Weight on Celanese, Lowers Price Target to $88

President-elect Donald Trump ran on a promise to <a href="https://www.benzinga.com/news/24/09/40703958/trumps-drill-baby-drill-pledge-may-not-deliver-promised-energy-price-cuts-experts-warn">&#8220;drill, baby, drill&#8221;</a> in his second term in office, reflecting his continued support of the fossil fuel industry. His stance on nuclear energy, however, is murky.
What Happened: Following his 2016 election win, Trump <a href="https://www.benzinga.com/news/16/12/8836138/trump-says-we-must-greatly-strengthen-expand-nuclear-capability">called for efforts to strengthen</a> U.S. nuclear energy. During his first term, his administration advanced several nuclear microreactor projects, <a href="https://www.energy.gov/ne/photos/11-accomplishments-trump-administration-advanced-nuclear-energy">according</a> to the Department of Energy.
However, he may have flip-flopped on the issue. In an interview with podcaster Joe Rogan ahead of the Nov. 5 election, Trump seemingly highlighted the dangers of pushing nuclear energy, <a href="https://www.huffpost.com/entry/trump-joe-rogan-nuclear-energy_n_671ec211e4b0448bcdb1e742">according</a> to the Huffington Post.
"They get too big and too complex and too expensive," Trump said. "There's a little danger to nuclear—you know, we had some really bad nuclear."
He then named several nuclear projects that have stalled in recent years.
Robert F. Kennedy Jr., an ally of Trump and a <a href="https://kalshi.com/markets/kxfda/next-fda-administrator">possible</a> Trump appointee, has an anti-nuclear track record, <a href="https://www.utilitydive.com/news/nuclear-energy-sector-mixed-views-second-trump-administration-joe-rogan/732407/">according</a> to Utility Dive.
See Also: <a href="https://www.benzinga.com/personal-finance/24/10/41313947/expert-finds-trumps-tax-proposal-drains-money-from-95-of-households-and-funnels-it-to-the-top-5-">Expert Finds Trump&#8217;s Tax Proposal Drains Money From 95% Of Households And Funnels It To The Top 5%</a>
Why it Matters: A future widespread adoption of nuclear energy <a href="https://www.benzinga.com/news/24/09/41020113/sam-altmans-openai-pushes-biden-administration-for-massive-5gw-data-centers-equivalent-to-output-of">necessitates significant investments</a> in data centers. In turn, data centers require substantially higher amounts of electricity. 
Artificial intelligence is <a href="https://www.benzinga.com/markets/esg/24/08/40589781/power-hungry-ai-revives-interest-in-nuclear-energy-michigan-to-reopen-closed-plant-for-first-time-in">projected to use</a> between 8% and 25% of all U.S. electricity by 2030.
Facts show that President Joe Biden&#8216;s administration produced <a href="https://www.benzinga.com/government/23/10/35240230/us-is-producing-more-oil-under-biden-than-at-any-point-under-the-trump-administration">more oil than Trump&#8217;s previous administration</a>. He also prioritized nuclear as a clean energy source. The one-term president positioned it as a bridge energy source that provides reliable, carbon-free electricity.
The Market Reacts: Regardless of whether he centers nuclear energy as a key part of his domestic agenda, Trump&#8217;s support of deregulation would likely serve as a tailwind.
Shares of Vistra Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VST#NYSE">VST</a>) have traded up over 13% since Trump&#8217;s election win. Constellation Energy Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CE#NASDAQ">CE</a>) has fared worse, trading down nearly 3%.
Small reactor companies have seen even more pronounced gains. Shares of Nuscale Power Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMR#NYSE">SMR</a>) are up over 20%. Meanwhile, Nano Nuclear Energy Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NNE#NASDAQ">NNE</a>) has shot up over 26%.
The Trump-Nuclear trade has seemingly died down on Monday and Tuesday. 
Also Read:
<ul>
<li><a href="https://www.benzinga.com/government/regulations/24/11/41909846/trumps-treasury-pick-frontrunner-scott-bessent-could-shift-wall-street-crypto">Trump&#8217;s Treasury Pick Frontrunner Scott Bessent Could Shift Wall Street, Crypto</a></li>
</ul>

Trump's Fossil Fuel Push May Satisfy AI's Soaring Energy Demand — But What About Nuclear?

WIIM

Celanese shares are trading lower after UBS downgraded the stock from Buy to Neutral and lowered its price target from $161 to $97.

UBS analyst Joshua Spector downgrades Celanese (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>) from Buy to Neutral and lowers the price target from $161 to $97.

Downgrades

UBS Downgrades Celanese to Neutral, Lowers Price Target to $97

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/587f78d077f9dd000126ef0f/john-difucci">Guggenheim analyst John Difucci</a> downgraded the rating for Smartsheet Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMAR#NYSE">SMAR</a>) from Buy to Neutral. Smartsheet shares closed at $56.02 on Friday. <a href="https://www.benzinga.com/quote/MSFT/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>JMP Securities analyst Constantine Davides downgraded the rating for agilon health, inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGL#NYSE">AGL</a>) from Market Outperform to Market Perform. Agilon Health shares closed at $1.84 on Friday. <a href="https://www.benzinga.com/quote/MSFT/analyst-ratings">See how other analysts view this stock</a>.</li>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/5abbc11ab0230000019a9b76/john-mcnulty">BMO Capital analyst John McNulty</a> downgraded Celanese Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>) from Market Perform to Underperform and lowered the price target from $138 to $76. Celanese shares closed at $84.80 on Friday. <a href="https://www.benzinga.com/quote/MSFT/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Seaport Global analyst Kenneth Zener downgraded the rating for NVR, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVR#NYSE">NVR</a>) from Buy to Neutral. NVR shares closed at $9,306.94 on Friday. <a href="https://www.benzinga.com/quote/MSFT/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Raymond James analyst James Rollyson downgraded Tidewater Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TDW#NYSE">TDW</a>) from Strong Buy to Outperform and slashed the price target from $131 to $102. Tidewater shares closed at $56.07 on Friday. <a href="https://www.benzinga.com/quote/MSFT/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying CE stock? Here&#8217;s what analysts think:
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="546" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/11071418/image-108-1024x546.png" alt="" class="wp-image-640254" style="width:508px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/11071418/image-108-1024x546.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/11071418/image-108-300x160.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/11071418/image-108-768x409.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/11071418/image-108.png 1242w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/11/41871463/dow-sp-500-notch-best-week-of-year-as-tesla-surges-post-trump-win-investor-sentiment-improves-fear-greed-index-remains-in-neutral-zone">Dow, S&amp;P 500 Notch Best Week Of Year As Tesla Surges Post Trump Win: Investor Sentiment Improves, Fear &amp; Greed Index Remains In &#8216;Neutral&#8217; Zone</a></li>
</ul>

Pre-Market Outlook

Markets

Trading Ideas

SMAR

This Celanese Analyst Turns Bearish; Here Are Top 5 Downgrades For Monday

BMO Capital analyst John McNulty downgrades Celanese (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>) from Market Perform to Underperform and lowers the price target from $138 to $76.

BMO Capital Downgrades Celanese to Underperform, Lowers Price Target to $76

The most oversold stocks in the materials sector presents an opportunity to buy into undervalued companies.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the <a href="https://www.benzinga.com/topic/rsi">RSI is below 30</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>.
Here's the latest list of major oversold players in this sector, having an RSI near or below 30.
<h3 class="wp-block-heading">Mativ Holdings Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MATV#NYSE">MATV</a>)</h3>
<ul>
<li>On Nov. 6, Mativ Holdings reported worse-than-expected third-quarter financial results. Chief Executive Officer Julie Schertell commented, &#8220;We saw meaningful increases in volume and profitability in Filtration and our overall SAS segment during the third quarter, with SAS segment adjusted EBITDA increasing almost 20% year over year. This was somewhat offset by results in Advanced Films, which were impacted by automotive and construction end markets." The company's stock fell around 12% over the past five days and has a <a href="https://www.benzinga.com/quote/MATV">52-week low of $10.78</a>.</li>
<li>RSI Value: 22.81&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
<li>MATV Price Action: Shares of Mativ dipped 21.1% to close at $13.73 on Thursday.</li>
<li>Benzinga Pro's real-time newsfeed alerted to <a href="https://www.benzinga.com/pro/?utm_source=BZprocontent110824&amp;t=be2bearmibe3na1">latest MATV news</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent110824&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="897" height="817" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/08040959/image-85.png" alt="" class="wp-image-637118" style="width:644px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/08040959/image-85.png 897w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/08040959/image-85-300x273.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/08040959/image-85-768x700.png 768w" sizes="(max-width: 897px) 100vw, 897px" /></a></figure>
<h3 class="wp-block-heading">Celanese Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>)</h3>
<ul>
<li>On Nov, 4, Celanese reported worse-than-expected third-quarter financial results and announced it intends to temporarily reduce its quarterly dividend. &#8220;In the third quarter, we faced a severely constrained demand environment that, in some cases like auto, degraded swiftly. I want to thank our teams for executing our value enhancing initiatives that are delivering improvements today while also laying the foundation for future growth,&#8221; said Lori Ryerkerk, chair and chief executive officer. The company's stock fell around 29% over the past five days and h<a href="https://www.benzinga.com/quote/CE">as a 52-week low</a> of $89.12.</li>
<li>RSI Value: 14.38</li>
<li>CE Price Action: Shares of Celanese fell 2.9% to close at $89.72 on Thursday.</li>
<li>Benzinga Pro&#8217;s charting tool helped identify the <a href="https://www.benzinga.com/pro/?utm_source=BZprocontent110824&amp;t=be2bearmibe3na1">trend in CE stock</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent110824&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="911" height="822" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/08041102/image-86.png" alt="" class="wp-image-637120" style="width:625px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/08041102/image-86.png 911w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/08041102/image-86-300x271.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/08041102/image-86-768x693.png 768w" sizes="(max-width: 911px) 100vw, 911px" /></a></figure>
<h3 class="wp-block-heading">Ashland Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASH#NYSE">ASH</a>)</h3>
<ul>
<li>On Nov. 6, Ashland reported worse-than-expected fourth-quarter financial results and issued FY25 revenue guidance below estimates. &#8220;Customer demand was generally consistent with our expectations in the fourth quarter and all business units delivered organic sales volume growth,&#8221; said Guillermo Novo, chair and chief executive officer, Ashland. The company's stock fell around 5% over the past five days and has a 52-week <a href="https://www.benzinga.com/quote/ASH">low of $71.55</a>.</li>
<li>RSI Value: 25.90</li>
<li>ASH Price Action: Shares of Ashland fell 7.6% to close at $80.70 on Thursday.</li>
<li>Benzinga Pro&#8217;s signals feature notified of a potential <a href="https://www.benzinga.com/pro/?utm_source=BZprocontent110824&amp;t=be2bearmibe3na1">breakout in ASH shares</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent110824&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="881" height="816" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/08041157/image-87.png" alt="" class="wp-image-637121" style="width:632px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/08041157/image-87.png 881w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/08041157/image-87-300x278.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/08041157/image-87-768x711.png 768w" sizes="(max-width: 881px) 100vw, 881px" /></a></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/24/11/41820056/how-to-earn-500-a-month-from-nvidia-stock-after-trump-win">How To Earn $500 A Month From Nvidia Stock After Trump Win</a></li>
</ul>

Long Ideas

MATV

Top 3 Materials Stocks That Are Preparing To Pump In Q4

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/587e3d7f5064ed0001730321/charles-neivert">Piper Sandler analyst Charles Neivert</a> downgraded the rating for Celanese Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>) from Neutral to Underweight and lowered the price target from $150 to $98. Celanese shares closed at $89.72 on Thursday. <a href="https://www.benzinga.com/quote/CE/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Macquarie analyst Paul Golding downgraded Planet Fitness, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLNT#NYSE">PLNT</a>) from Outperform to Neutral but raised the price target from $91 to $99. Planet Fitness shares closed at $94.17 on Thursday. <a href="https://www.benzinga.com/quote/PLNT/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>RBC Capital analyst Mike Dahl downgraded the rating for Installed Building Products, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IBP#NYSE">IBP</a>) from Sector Perform to Underperform and lowered the price target from $203 to $197. Installed Building Prods shares closed at $217.27 on Thursday. <a href="https://www.benzinga.com/quote/IBP/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Barclays analyst Adrienne Yih downgraded Bath &amp; Body Works, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBWI#NYSE">BBWI</a>) from Equal-Weight to Underweight and lowered the price target from $31 to $28. Bath &amp; Body Works shares closed at $31.75 on Thursday. <a href="https://www.benzinga.com/quote/BBWI/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>William Blair analyst Matt Larew downgraded the rating for Maravai LifeSciences Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRVI#NASDAQ">MRVI</a>) from Outperform to Market Perform. Maravai LifeSciences shares closed at $7.84 on Thursday. <a href="https://www.benzinga.com/quote/MRVI/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying CE stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="539" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/08084942/image-93-1024x539.png" alt="" class="wp-image-637660" style="width:578px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/08084942/image-93-1024x539.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/08084942/image-93-300x158.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/08084942/image-93-768x404.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/08084942/image-93.png 1255w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/markets/24/11/41820056/how-to-earn-500-a-month-from-nvidia-stock-after-trump-win">How To Earn $500 A Month From Nvidia Stock After Trump Win</a></li>
</ul>

BBWI

MRVI

PLNT

This Celanese Analyst Turns Bearish; Here Are Top 5 Downgrades For Friday

Piper Sandler analyst Charles Neivert downgrades Celanese (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>) from Neutral to Underweight and lowers the price target from $150 to $98.

Piper Sandler Downgrades Celanese to Underweight, Lowers Price Target to $98

RBC Capital analyst Arun Viswanathan maintains Celanese (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>) with a Outperform and lowers the price target from $163 to $122.

RBC Capital Maintains Outperform on Celanese, Lowers Price Target to $122

Deutsche Bank analyst David Begleiter upgraded Celanese Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>) to Buy from Hold, lowering the price forecast to $110 from $135.
Celanese reported third-quarter adjusted earnings per share of $2.44, missing analyst estimates of $2.85. The company reported sales of $2.65 billion, missing analyst estimates of $2.7 billion, according to&nbsp;<a target="_blank" href="http://pro.benzinga.com/" rel="noreferrer noopener">Benzinga Pro</a>.
The analyst wasn&#8217;t surprised by Celanese missing third-quarter earnings and lowering fourth-quarter guidance.
For Begleiter, the shortfalls were due to weak demand in automotive, industrial and construction markets, which impacted many chemical companies this earnings season.
Particularly, the 57% fourth-quarter guidance shortfall surprised the analyst, but it was mainly due to temporary facility shutdowns to cut costs and reduce inventory.
Also Read: <a target="_blank" href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41780680/super-micro-analysts-need-more-clarity-on-auditor-resignation-await-10-k-filing-man" rel="noreferrer noopener">Super Micro Analysts Need More Clarity On Auditor Resignation, Await 10-K Filing: &#8216;Management Did Not Address These Topics&#8217;</a>
Celanese likely misjudged the auto market, overproducing in the third quarter and creating excess inventory.
Begleiter added this won&#8217;t affect the company&#8217;s long-term earnings potential.
The analyst noted the 95% dividend cut should have happened two years ago when Celanese acquired DuPont&#8217;s Mobility &amp; Materials business for $11 billion.
Now, two years post-acquisition, Celanese is 5x leveraged (4.9x net debt to LTM EBITDA), leaving little margin for error.
The analyst suggested Celanese has strong operating leverage for a recovery, forecasting its EPS will rise from $10.50 in 2025 to over $14.50 by 2026, driven by factors such as interest rate cuts in Western countries, fiscal and monetary stimulus in China and several years of low industrial activity.
CE Price Action: Celanese shares are trading higher by 1.03% to $91.94 at publication Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41778433/s-p-500-dow-hit-record-highs-after-trump-win-fear-index-drops-20" target="_blank" rel="noreferrer noopener">S&amp;P 500, Dow Hit Record Highs After Trump Win; Fear Index Drops 20%</a></li>
</ul>

Equities

Movers

General

Deutsche Bank Upgrades Celanese Stock: Analyst Highlights Strong Leverage, Long-Term Growth

Barclays analyst Michael Leithead maintains Celanese (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>) with a Equal-Weight and lowers the price target from $151 to $101.

Barclays Maintains Equal-Weight on Celanese, Lowers Price Target to $101

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/580f253b846faa000139ba71/robert-moskow">TD Cowen analyst Robert Moskow</a> upgraded the rating for The Clorox Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLX#NYSE">CLX</a>) from Sell to Hold and raises the price target from $155 to $170. Clorox shares closed at $162.42 on Tuesday. <a href="https://www.benzinga.com/quote/CLX/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Barclays analyst Trevor Young upgraded Revolve Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RVLV#NYSE">RVLV</a>) from Underweight to Equal-Weight and raised the price target from $17 to $25. Revolve shares closed at $26.02 on Tuesday. <a href="https://www.benzinga.com/quote/RVLV/analyst-ratings">See how other analysts view this stock</a>.</li>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/616e99feb650db000151570b/rick-bienkowski">Leerink Partners analyst Rick Bienkowski</a> upgraded the rating for Beam Therapeutics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BEAM#NASDAQ">BEAM</a>) from Market Perform to Outperform and increased the price target from $27 to $39. Beam Therapeutics shares closed at $23.93 on Tuesday. <a href="https://www.benzinga.com/quote/BEAM/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Deutsche Bank analyst David Begleiter upgraded Celanese Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>) from Hold to Buy and lowered the price target from $135 to $110. Celanese shares closed at $91.00 on Tuesday. <a href="https://www.benzinga.com/quote/CE/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>

Considering buying CLX stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="547" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/06082758/image-49-1024x547.png" alt="" class="wp-image-632747" style="width:636px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/06082758/image-49-1024x547.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/06082758/image-49-300x160.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/06082758/image-49-768x410.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/06082758/image-49.png 1230w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/11/41744659/jim-cramer-says-he-cant-recommend-this-major-automaker-ceva-is-way-too-high">Jim Cramer Says He Can&#8217;t Recommend This Major Automaker, Ceva Is &#8216;Way Too High&#8217;</a></li>
</ul>

Upgrades

BEAM

RVLV

This Clorox Analyst Is No Longer Bearish; Here Are Top 4 Upgrades For Wednesday

Baird analyst Ghansham Panjabi maintains Celanese (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>) with a Outperform and lowers the price target from $150 to $110.

Baird Maintains Outperform on Celanese, Lowers Price Target to $110

Morgan Stanley analyst Vincent Andrews maintains Celanese (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>) with a Equal-Weight and lowers the price target from $140 to $100.

Morgan Stanley Maintains Equal-Weight on Celanese, Lowers Price Target to $100

Deutsche Bank analyst David Begleiter upgrades Celanese (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>) from Hold to Buy and lowers the price target from $135 to $110.

Deutsche Bank Upgrades Celanese to Buy, Lowers Price Target to $110

Celanese Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>) shares are tumbling on Tuesday after the company reported worse-than-expected third-quarter financial results and announced it intends to temporarily reduce its <a href="https://www.benzinga.com//node/41728472">quarterly dividend</a>.
What Happened: Celanese reported third-quarter adjusted earnings per share of $2.44, missing analyst estimates of $2.85. The company reported sales of $2.65 billion, missing analyst estimates of $2.7 billion, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Celanese reported adjusted EBIT of $457 million, operating EBITDA of $644 million and operating profit of $248 million.
The company stated in its earnings release that it has implemented multiple measures to address challenges in the demand environment. Notably, it plans to reduce its quarterly dividend by approximately 95%, starting in the first quarter of 2025.
&#8220;In the third quarter, we faced a severely constrained demand environment that, in some cases like auto, degraded swiftly. I want to thank our teams for executing our value enhancing initiatives that are delivering improvements today while also laying the foundation for future growth,&#8221; said Lori Ryerkerk, chair and CEO of Celanese.
&#8220;Still, these actions have been increasingly offset in the current environment and the earnings generated fell short of our expectations. In response we are taking additional measures to navigate current challenges while positioning Celanese for long-term success. We are confident these actions will accelerate our growth and enhance long-term value.&#8221;
Related Link: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41732827/messi-of-ai-wall-street-analyst-gushes-over-robust-earnings-from-palantir">&#8216;Messi Of AI&#8217;: Wall Street Analyst Gushes Over &#8216;Robust&#8217; Earnings From Palantir</a>
Celanese said it reduced its manufacturing costs by temporarily halting production at select facilities worldwide. The company anticipates a $200 million boost in cash flow from inventory reductions in the fourth quarter. Celanese noted that it&#8217;s targeting over $75 million in savings by the end of 2025.
Following the company&#8217;s earnings report, Wells Fargo analyst Michael Sison downgraded Celanese from an <a href="https://www.benzinga.com/analyst-stock-ratings">Overweight rating</a> to an Equal-Weight rating and lowered the price target from $165 to $115. Mizuho analyst Kieran De Brun maintained a Neutral rating and lowered the price target from $132 to $120.
CE Price Action: At the time of publication, Celanese shares are down 24.7%, trading at $93.15, according to data from <a href="https://www.benzinga.com/pro/">Benzinga Pro.</a>
Image: 777546 from Pixabay

Earnings

What's Going On With Celanese Stock Tuesday?

Mizuho analyst Kieran De Brun maintains Celanese (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>) with a Neutral and lowers the price target from $132 to $120.

Mizuho Maintains Neutral on Celanese, Lowers Price Target to $120

U.S. stock futures were slightly higher this morning, with the Dow futures gaining around 0.1% on Tuesday.
Shares of Celanese Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>) fell sharply in today's pre-market trading after the company reported worse-than-expected third-quarter financial results and announced it intends to temporarily reduce its quarterly dividend.
Celanese reported quarterly earnings of $2.44 per share which missed the analyst consensus estimate of $2.85 per share. The company reported quarterly sales of $2.65 billion which missed the analyst consensus estimate of $2.70 billion.
Celanese shares dipped 15.8% to $103.89 in the pre-market trading session.
Here are some other stocks moving lower in pre-market trading.
<ul>
<li>Navitas Semiconductor Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVTS#NASDAQ">NVTS</a>) shares fell 19.4% to $2.10 in pre-market trading after the company reported weak third-quarter sales.</li>
<li>JELD-WEN Holding, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JELD#NYSE">JELD</a>) shares declined 18.5% to $11.51 in pre-market trading after the company reported downbeat quarterly results and lowered FY24 sales forecast.</li>
<li>Lattice Semiconductor Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LSCC#NASDAQ">LSCC</a>) declined 18% to $42.55 in pre-market trading following soft fourth-quarter guidance.</li>
<li>Altice USA, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATUS#NYSE">ATUS</a>) fell 14.3% to $2.22 in pre-market trading after the company reported weak third-quarter financial results.</li>
<li>MediaAlpha, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MAX#NYSE">MAX</a>) declined 13% to $13.99 in pre-market trading.</li>
<li>Tactile Systems Technology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCMD#NASDAQ">TCMD</a>) fell 10.3% to $13.55 in pre-market trading after the company posted weak quarterly sales and lowered FY24 sales forecast.</li>
<li>Cirrus Logic, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRUS#NASDAQ">CRUS</a>) shares fell 9.7% to $99.83 in pre-market trading following second-quarter results.</li>
<li>Apellis Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APLS#NASDAQ">APLS</a>) dipped 9.5% to $25.84 in pre-market trading following weak quarterly results.</li>
<li>Cleveland-Cliffs Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLF#NYSE">CLF</a>) shares fell 6.5% to $12.26 in pre-market trading following downbeat third-quarter results.</li>
<li>Teradata Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TDC#NYSE">TDC</a>) shares declined 5.6% to $31.51 in pre-market trading after reporting third-quarter results.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/11/41740698/top-3-health-care-stocks-youll-regret-missing-in-november">Top 3 Health Care Stocks You&#8217;ll Regret Missing In November</a></li>
</ul>

APLS

ATUS

CRUS

JELD

LSCC

NVTS

TCMD

Celanese Posts Downbeat Results, Joins Cirrus Logic, Teradata And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

Short sellers boost bets against materials stocks amid demand uncertainty

How is VOO stock faring? The Vanguard S&P 500 ETF is down 1.04% in the past five days but has risen 34.7% over the past year.  According to TipRank...

VOO ETF Update, 11/15/2024

MXI: Materials Dashboard For November

Over the past 12 months, a group of 10 large-cap stocks have underperformed all others. Here's an updated look at the top 10 worst performing large-caps, along with their one-year price returns.

Large-Cap Stocks In Trouble - Sunday, Nov. 17

In a report released today, Michael Leithead from Barclays maintained a Hold rating on Celanese (CE – Research Report), with a price target of $88....

Barclays Reaffirms Their Hold Rating on Celanese (CE)

Barclays lowered the firm's price target on Celanese (CE) to $88 from $101 and keeps an Equal Weight rating on the shares. The firm analyzed the to...

Celanese price target lowered to $88 from $101 at Barclays

Henkel Corporation and Celanese (CE) Corporation, a global chemical and specialty materials company, have announced a partnership to enhance circul...

Comments

Celanese

Notizie

Ultime notizie per Celanese (NYSE:CE) Azioni

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO